TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
GOSS

Gossamer Bio Inc

Healthcare · Biotechnology

11.70$ +3.6% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GOSS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 100.0% 96.9% 95.9% 96.8% 96.5% 96.1% 98.3% 98.3% 97.3%
100.0% 70.8% 43.9% 31.7% 90.1% 53.4% 41.1% 10.3% 14.6% 21.9%
100.0% 70.8% 95.5% 94.2% 95.0% 94.6% 93.8% 95.0% 93.4% 79.5%
0.2% 0.4% 0.0% 0.1% 1.7% 7.3%
-0.4% 0.1% 0.0%
1.3% 3.7% 1.0% 1.5% 1.5%
305.0% 1,642.0% 150.2% 17.4% 40.6% 64.7% 95.6% 79.9% 90.6% 171.3%
238.3% 284.5% 8.5% 8.7% 7.2% 11.6% 18.1% 16.5% 14.3% 36.8%
0.6% 0.7% 0.8% 5.4% 4.8% 0.3% 0.5%
66.7% 21.8% 0.9% 0.2% 1.4% 0.9% 0.5% 1.8% 0.7% 3.5%
66.7% 1,357.3% 6.7% 32.0% 52.1% 76.2% 63.3% 62.6% 115.2%
-205.0% -1,542.0% -50.2% 82.6% 59.4% 35.3% 4.4% 20.1% 9.4% -71.3%
-205.0% -1,549.2% -64.3% -78.3% -107.1% -236.1% -378.9% -388.6% -402.3% -835.4%
15,268.0% 5,580.1% 25.2% 12.8% 12.7% 21.8% 0.4% 0.6% 0.9% 1.7%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?